ReviewPulmonary circulation2022

Emerging therapies: The potential roles SGLT2 inhibitors, GLP1 agonists, and ARNI therapy for ARNI pulmonary hypertension.

Nicholas E King et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.